Profiling Y561-Dependent and -Independent Substrates of CSF-1R in Epithelial Cells

Receptor tyrosine kinases (RTKs) activate multiple downstream cytosolic tyrosine kinases following ligand stimulation. SRC family kinases (SFKs), which are recruited to activated RTKs through SH2 domain interactions with RTK autophosphorylation sites, are targets of many subfamilies of RTKs. To date, there has not been a systematic analysis of the downstream substrates of such receptor-activated SFKs. Here, we conducted quantitative mass spectrometry utilizing stable isotope labeling (SILAC) analysis to profile candidate SRC-substrates induced by the CSF-1R tyrosine kinase by comparing the phosphotyrosine-containing peptides from cells expressing either CSF-1R or a mutant form of this RTK that is unable to bind to SFKs. This analysis identified previously uncharacterized changes in tyrosine phosphorylation induced by CSF-1R in mammary epithelial cells as well as a set of candidate substrates dependent on SRC recruitment to CSF-1R. Many of these candidates may be direct SRC targets as the amino acids flanking the phosphorylation sites in these proteins are similar to known SRC kinase phosphorylation motifs. The putative SRC-dependent proteins include known SRC substrates as well as previously unrecognized SRC targets. The collection of substrates includes proteins involved in multiple cellular processes including cell-cell adhesion, endocytosis, and signal transduction. Analyses of phosphoproteomic data from breast and lung cancer patient samples identified a subset of the SRC-dependent phosphorylation sites as being strongly correlated with SRC activation, which represent candidate markers of SRC activation downstream of receptor tyrosine kinases in human tumors. In summary, our data reveal quantitative site-specific changes in tyrosine phosphorylation induced by CSF-1R activation in epithelial cells and identify many candidate SRC-dependent substrates phosphorylated downstream of an RTK.

[1]  G. Hampton,et al.  A phosphoproteomic analysis of the ErbB2 receptor tyrosine kinase signaling pathways. , 2006, Biochemistry.

[2]  L. Luttrell,et al.  c-Src-mediated phosphorylation of AP-2 reveals a general mechanism for receptors internalizing through the clathrin pathway. , 2009, Cellular signalling.

[3]  E. Sapi The Role of CSF-1 in Normal Physiology of Mammary Gland and Breast Cancer: An Update , 2004, Experimental biology and medicine.

[4]  H. Stenmark,et al.  Hrs and endocytic sorting of ubiquitinated membrane proteins. , 2002, Cell Structure and Function.

[5]  S. Chambers,et al.  The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma. , 2001, Gynecologic oncology.

[6]  Akhilesh Pandey,et al.  Identification of c-Src Tyrosine Kinase Substrates Using Mass Spectrometry and Peptide Microarrays , 2008, Journal of proteome research.

[7]  S. Gygi,et al.  An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets , 2005, Nature Biotechnology.

[8]  C. D’Souza-Schorey,et al.  Lysosomal Targeting of E-Cadherin: a Unique Mechanism for the Down-Regulation of Cell-Cell Adhesion during Epithelial to Mesenchymal Transitions , 2005, Molecular and Cellular Biology.

[9]  S. K. Shore,et al.  SRC in human carcinogenesis. , 2003, Frontiers in bioscience : a journal and virtual library.

[10]  G. Gallick,et al.  Src family kinases in tumor progression and metastasis , 2003, Cancer and Metastasis Reviews.

[11]  Y. Yarden,et al.  Oncogenic growth factor receptors: implications for signal transduction therapy. , 2004, Seminars in cancer biology.

[12]  Michael B. Yaffe,et al.  Scansite 2.0: proteome-wide prediction of cell signaling interactions using short sequence motifs , 2003, Nucleic Acids Res..

[13]  W. Birchmeier,et al.  Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex , 2002, Nature Cell Biology.

[14]  Richard D. Smith,et al.  An extensive survey of tyrosine phosphorylation revealing new sites in human mammary epithelial cells. , 2009, Journal of proteome research.

[15]  J. Tavaré,et al.  The Identification of ATP-citrate Lyase as a Protein Kinase B (Akt) Substrate in Primary Adipocytes* , 2002, The Journal of Biological Chemistry.

[16]  S. Courtneidge Role of Src in Signal Transduction Pathways , 2001 .

[17]  A. Tyner,et al.  RAKing in AKT: A tumor suppressor function for the intracellular tyrosine kinase FRK , 2009, Cell cycle.

[18]  F. van Roy,et al.  A novel role for p120 catenin in E-cadherin function , 2002, The Journal of cell biology.

[19]  M. Myers,et al.  Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies. , 2008, International immunopharmacology.

[20]  S. Parsons,et al.  c-Src and cooperating partners in human cancer. , 2004, Cancer cell.

[21]  M. Carcangiu,et al.  Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[22]  Y. Ishikawa,et al.  ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. , 2008, Cancer research.

[23]  Jayanta Debnath,et al.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. , 2003, Methods.

[24]  Sheila M. Thomas,et al.  Cellular functions regulated by Src family kinases. , 1997, Annual review of cell and developmental biology.

[25]  M. Jett,et al.  Metastatic progression and gene expression between breast cancer cell lines from African American and Caucasian women , 2007, Journal of carcinogenesis.

[26]  Cédric Leroy,et al.  Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells. , 2009, Cancer research.

[27]  G. Daley,et al.  Novel role for PDEF in epithelial cell migration and invasion. , 2005, Cancer research.

[28]  L. Cantley,et al.  Recognition and specificity in protein tyrosine kinase-mediated signalling. , 1995, Trends in biochemical sciences.

[29]  J. Kornhauser,et al.  PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation , 2004, Proteomics.

[30]  Yiling Lu,et al.  Rak functions as a tumor suppressor by regulating PTEN protein stability and function. , 2009, Cancer cell.

[31]  Jeffrey Wyckoff,et al.  Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor. , 2009, Cancer research.

[32]  L. Putignani,et al.  Alteration of expression levels of the oxidative phosphorylation system (OXPHOS) in breast cancer cell mitochondria , 2008, Breast Cancer Research and Treatment.

[33]  S. Alemà,et al.  p120 catenin and phosphorylation: Mechanisms and traits of an unresolved issue. , 2007, Biochimica et biophysica acta.

[34]  M. Roussel,et al.  Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture , 2004, The Journal of cell biology.

[35]  J. Hardin,et al.  Making and breaking contacts: the cellular biology of cadherin regulation. , 2007, Current opinion in cell biology.

[36]  R. Cole,et al.  Identification of c‐Src tyrosine kinase substrates in platelet‐derived growth factor receptor signaling , 2009, Molecular oncology.

[37]  U. Novak,et al.  Expression of a Y559F mutant CSF-1 receptor in M1 myeloid cells: a role for Src kinases in CSF-1 receptor-mediated differentiation. , 1999, Molecular cell biology research communications : MCBRC.

[38]  N. Carragher,et al.  v-SRC'S hold over actin and cell adhesions , 2002, Nature Reviews Molecular Cell Biology.

[39]  R. Finn,et al.  Targeting Src in breast cancer. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[40]  N. Hynes,et al.  ErbB receptors and signaling pathways in cancer. , 2009, Current opinion in cell biology.

[41]  Xavier Estivill,et al.  Intersectin 2, a new multimodular protein involved in clathrin‐mediated endocytosis , 2000, FEBS letters.

[42]  M. Mann,et al.  Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. , 2003, Analytical chemistry.

[43]  K. Green,et al.  Targeting of p0071 to desmosomes and adherens junctions is mediated by different protein domains , 2003, Journal of Cell Science.

[44]  B. Kacinski CSF‐1 and its receptor in breast carcinomas and neoplasms of the female reproductive tract , 1997, Molecular Reproduction and Development.

[45]  F. Pixley,et al.  CSF-1 regulation of the wandering macrophage: complexity in action. , 2004, Trends in cell biology.

[46]  A. Pandey,et al.  Global impact of oncogenic Src on a phosphotyrosine proteome. , 2008, Journal of proteome research.

[47]  Joshua E. Elias,et al.  Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. , 2003, Journal of proteome research.

[48]  E. Stanley,et al.  Proteomic Approaches to the Analysis of Early Events in Colony-stimulating Factor-1 Signal Transduction* , 2003, Molecular & Cellular Proteomics.

[49]  S. Courtneidge,et al.  The interplay between Src family kinases and receptor tyrosine kinases , 2004, Oncogene.

[50]  Ron Bose,et al.  Phosphoproteomic analysis of Her2/neu signaling and inhibition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Laura A. Sullivan,et al.  Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer , 2007, Cell.

[52]  I. Madshus,et al.  Hrs sorts ubiquitinated proteins into clathrin-coated microdomains of early endosomes , 2002, Nature Cell Biology.

[53]  M. Koegl,et al.  Sequence Requirements for Binding of Src Family Tyrosine Kinases to Activated Growth Factor Receptors (*) , 1995, The Journal of Biological Chemistry.

[54]  Albert B. Reynolds,et al.  A core function for p120-catenin in cadherin turnover , 2003, The Journal of cell biology.

[55]  A. Reynolds p120-catenin: Past and present. , 2007, Biochimica et biophysica acta.

[56]  R. Halaban,et al.  Recognition of activated CSF-1 receptor in breast carcinomas by a tyrosine 723 phosphospecific antibody , 1997, Oncogene.

[57]  T. Mak,et al.  Metabolic Targeting as an Anticancer Strategy: Dawn of a New Era? , 2007, Science's STKE.

[58]  Timothy J. Yeatman,et al.  A renaissance for SRC , 2004, Nature Reviews Cancer.

[59]  S. Courtneidge Role of Src in signal transduction pathways. The Jubilee Lecture. , 2002, Biochemical Society transactions.

[60]  J. Rush,et al.  Immunoaffinity profiling of tyrosine phosphorylation in cancer cells , 2005, Nature Biotechnology.

[61]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[62]  P. Jänne,et al.  Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer , 2008, Clinical Cancer Research.

[63]  H. Stenmark,et al.  Function of Hrs in endocytic trafficking and signalling. , 2001, Biochemical Society transactions.

[64]  H. Kantarjian,et al.  The role of Src in solid and hematologic malignancies , 2006, Cancer.

[65]  Angel W. Lee,et al.  A Juxtamembrane Tyrosine in the Colony Stimulating Factor-1 Receptor Regulates Ligand-induced Src Association, Receptor Kinase Function, and Down-regulation* , 2004, Journal of Biological Chemistry.

[66]  P. Perrotta,et al.  Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.